자가 검사 시장 규모, 점유율, 동향 분석 : 제품별, 검체별, 용도별, 유통 채널별, 사용법별, 지역별, 부문별 예측(2026-2033년)

Self-testing Market Summary

The global self-testing market size was estimated at USD 11.78 billion in 2025 and is expected to reach USD 21.92 billion by 2033, growing at a CAGR of 8.46% from 2026 to 2033. This growth is driven by increasing emphasis on personalized healthcare, technological advancements in rapid diagnostics, and rising demand for convenient and rapid diagnostics kits. Self-test/kits are used for rapid diagnosis of a wide variety of illnesses.

Furthermore, rising awareness about the benefits of early diagnosis and regular monitoring has boosted the uptake of self-testing devices, and an increasing number of product launches are also expected to have a positive impact on the market. The COVID-19 pandemic has accelerated the need and emphasis on self-testing kits with an aim to increase the rate of diagnosis. To reduce the risk of serious disease, hospitalizations, or death, many organizations have implemented various efforts. For instance, the Administration for Strategic Preparedness and Response (ASPR) and NIH collaborated to launch the Home Test to Treat programme in January 2024. This programme is a virtual community health intervention that will provide free COVID health services, such as telehealth consultations, home treatments, and at-home rapid tests, in a few selected communities. Such factors further boost the market.

Growing regulatory approvals are driving market expansion by instilling confidence in self-testing products. As more diagnostic tools receive approval from reputable regulatory bodies, including the WHO and FDA, they gain broader acceptance and credibility. This encourages adoption by both consumers and healthcare providers, facilitating access to accurate, reliable testing options. Regulatory approvals not only ensure product safety but also create pathways for market growth, promoting the development and availability of new self-testing solutions across various healthcare sectors. For instance, in July 2022, Innova secured a CE mark for its rapid antigen self-test, allowing the company to distribute the product across European markets. This approval provides a significant boost to the availability of at-home COVID-19 testing solutions, enabling easier access for consumers and enhancing the capacity to manage the pandemic. The CE mark indicates that the test meets the European Union's safety, health, and environmental protection standards, reinforcing confidence in its reliability and effectiveness.

In addition, increasing funding and investments by various organizations, as well as market players, for the development of robust and novel diagnostics has created beneficial opportunities for the market. For instance, in January 2022, the Florida Atlantic University (FAU) approved funding of USD 1.3 million to NIH for the development of quick and automated HIV self-kits. Furthermore, in April 2022, India-based start-up Cervicheck received approval from the Central Drugs Standard Control Organization (CDSCO) for its commercialization in India. The kit is used for the diagnosis of Human Papillomavirus (HPV).

Integration with telehealth services represents another major advancement driving the adoption of self-testing solutions. Remote consultation capabilities allow individuals to perform tests at home and immediately connect with healthcare professionals for interpretation, diagnosis, or treatment recommendations. This seamless connection between testing and clinical guidance improves healthcare accessibility, particularly for individuals in remote or underserved areas. Telehealth integration also supports chronic disease management by enabling continuous monitoring and timely medical interventions without requiring in-person visits. Healthcare systems are increasingly adopting digital ecosystems that combine diagnostics, data analytics, and virtual care, creating new opportunities for self-testing technologies. As telemedicine becomes more widely accepted, the demand for connected diagnostic tools that integrate with virtual healthcare platforms is expected to grow substantially. For instance, in April 2025, the Intro-Act Healthtech Newsletter, citing BioSpace news, reported that an AI-enabled home sleep apnea test wearable had received FDA 510(k) clearance, providing multi-night testing and severity identification validated against polysomnography, demonstrating the growing convergence of digital health, home diagnostics, and remote care technologies.

Global Self-testing Market Report Segmentation

This report forecasts revenue growth at global, regional, & country levels and provides an analysis of industry trends in each of the subsegments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global self-testing market report based on product, sample, application, distribution channel, usage, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Kits
• Devices
• Strips
• Sample Outlook (Revenue, USD Million, 2021 - 2033)
• Blood
• Urine
• Stool
• Swab
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Blood Pressure Test
• Diabetes and Glucose Tests
• Cholesterol and Triglycerides Tests
• Pregnancy Test
• STD /STI Test
• Urinary Tract Infection Test
• Anemia Test
• Allergy Test
• Others
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Online
• Offline
• Usage Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Disposable
• Reusable
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Sample Segment
  • 1.2.3. Application Segment
  • 1.2.4. Distribution Channel Segment
  • 1.2.5. Usage Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Global Self-Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of chronic and infectious diseases
    • 3.2.1.2. Advancements in diagnostic technology
    • 3.2.1.3. Growing regulatory approvals
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High initial costs for advanced kits
    • 3.2.2.2. Limited awareness in emerging markets
• 3.3. Global Self-Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Global Self-Testing Market: Sample Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Self-Testing Market Sample Movement Analysis
• 4.3. Global Self-Testing Market Size & Trend Analysis, by Sample, 2021 to 2033 (USD Million)
• 4.4. Blood
  • 4.4.1. Blood market estimates and forecast, 2021 - 2033 (USD Million)
• 4.5. Urine
  • 4.5.1. Urine market estimates and forecast, 2021 - 2033 (USD Million)
• 4.6. Stool
  • 4.6.1. Stool market estimates and forecast, 2021 - 2033 (USD Million)
• 4.7. Swab
  • 4.7.1. Swab market estimates and forecast, 2021 - 2033 (USD Million)
• 4.8. Others
  • 4.8.1. Others market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 5. Global Self-Testing Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Self-Testing Market Product Movement Analysis
• 5.3. Global Self-Testing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 5.4. Kits
  • 5.4.1. Kits market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Devices
  • 5.5.1. Devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Strips
  • 5.6.1. Strips market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Global Self-Testing Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Self-Testing Market Application Movement Analysis
• 6.3. Global Self-Testing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Blood Pressure Test
  • 6.4.1. Blood pressure test market estimates and forecast, 2021 - 2033 (USD Million)
• 6.5. Diabetes and Glucose
  • 6.5.1. Diabetes and glucose market estimates and forecast, 2021 - 2033 (USD Million)
• 6.6. Cholesterol and Triglycerides Tests
  • 6.6.1. Cholesterol and triglycerides tests market estimates and forecast, 2021 - 2033 (USD Million)
• 6.7. Pregnancy Test
  • 6.7.1. Pregnancy test market estimates and forecast, 2021 - 2033 (USD Million)
• 6.8. STD /STI Test
  • 6.8.1. STD /STI test market estimates and forecast, 2021 - 2033 (USD Million)
• 6.9. Urinary Tract Infection Test
  • 6.9.1. Urinary tract infection test market estimates and forecast, 2021 - 2033 (USD Million)
• 6.10. Anemia Test
  • 6.10.1. Anemia test market estimates and forecast, 2021 - 2033 (USD Million)
• 6.11. Allergy Test
  • 6.11.1. Allergy test market estimates and forecast, 2021 - 2033 (USD Million)
• 6.12. Others
  • 6.12.1. Others market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. Global Self-Testing Market: Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Self-Testing Market Distribution Channel Movement Analysis
  • 7.2.1. Global Self-Testing Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
• 7.3. Online
  • 7.3.1. Online market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.4. Offline
  • 7.4.1. Offline market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Global Self-Testing Market: Usage Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Self-Testing Market Usage Movement Analysis
  • 8.2.1. Global Self-Testing Market Size & Trend Analysis, by usage, 2021 to 2033 (USD Million)
• 8.3. Disposable
  • 8.3.1. Disposable market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.4. Reusable
  • 8.4.1. Reusable market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Self-Testing Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 9.3. North America
  • 9.3.1. U.S.
    • 9.3.1.1. Key country dynamics
    • 9.3.1.2. Regulatory framework/ reimbursement structure
    • 9.3.1.3. Competitive scenario
    • 9.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. Canada
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Regulatory framework/ reimbursement structure
    • 9.3.2.3. Competitive scenario
    • 9.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Mexico
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Regulatory framework/ reimbursement structure
    • 9.3.3.3. Competitive scenario
    • 9.3.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Regulatory framework/ reimbursement structure
    • 9.4.1.3. Competitive scenario
    • 9.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework/ reimbursement structure
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework/ reimbursement structure
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework/ reimbursement structure
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Regulatory framework/ reimbursement structure
    • 9.4.5.3. Competitive scenario
    • 9.4.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Norway
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Regulatory framework/ reimbursement structure
    • 9.4.6.3. Competitive scenario
    • 9.4.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Regulatory framework/ reimbursement structure
    • 9.4.7.3. Competitive scenario
    • 9.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Regulatory framework/ reimbursement structure
    • 9.4.8.3. Competitive scenario
    • 9.4.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework/ reimbursement structure
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework/ reimbursement structure
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. India
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework/ reimbursement structure
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. Australia
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework/ reimbursement structure
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework/ reimbursement structure
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework/ reimbursement structure
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework/ reimbursement structure
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework/ reimbursement structure
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework/ reimbursement structure
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework/ reimbursement structure
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework/ reimbursement structure
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework/ reimbursement structure
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2023
• 10.4. List of Key Certification Providers/Scheme Owners
• 10.5. Company Profiles/Listing
  • 10.5.1. Geratherm Medical AG
    • 10.5.1.1. Company overview
    • 10.5.1.2. Financial performance
    • 10.5.1.3. Product benchmarking
    • 10.5.1.4. Strategic initiatives
  • 10.5.2. Cardinal Health
    • 10.5.2.1. Company overview
    • 10.5.2.2. Financial performance
    • 10.5.2.3. Product benchmarking
    • 10.5.2.4. Strategic initiatives
  • 10.5.3. OraSure Technologies, Inc.
    • 10.5.3.1. Company overview
    • 10.5.3.2. Financial performance
    • 10.5.3.3. Product benchmarking
    • 10.5.3.4. Strategic initiatives
  • 10.5.4. bioLytical Laboratories Inc.
    • 10.5.4.1. Company overview
    • 10.5.4.2. Financial performance
    • 10.5.4.3. Product benchmarking
    • 10.5.4.4. Strategic initiatives
  • 10.5.5. PRIMA Lab SA.
    • 10.5.5.1. Company overview
    • 10.5.5.2. Financial performance
    • 10.5.5.3. Product benchmarking
    • 10.5.5.4. Strategic initiatives
  • 10.5.6. BD
    • 10.5.6.1. Company overview
    • 10.5.6.2. Financial performance
    • 10.5.6.3. Product benchmarking
    • 10.5.6.4. Strategic initiatives
  • 10.5.7. F. Hoffmann-La Roche Ltd.
    • 10.5.7.1. Company overview
    • 10.5.7.2. Financial performance
    • 10.5.7.3. Product benchmarking
    • 10.5.7.4. Strategic initiatives
  • 10.5.8. Bionime Corporation
    • 10.5.8.1. Company overview
    • 10.5.8.2. Financial performance
    • 10.5.8.3. Product benchmarking
    • 10.5.8.4. Strategic initiatives
  • 10.5.9. Abbott
    • 10.5.9.1. Company overview
    • 10.5.9.2. Financial performance
    • 10.5.9.3. Product benchmarking
    • 10.5.9.4. Strategic initiatives
  • 10.5.10. Everlywell, Inc.
    • 10.5.10.1. Company overview
    • 10.5.10.2. Financial performance
    • 10.5.10.3. Product benchmarking
    • 10.5.10.4. Strategic initiatives